261 related articles for article (PubMed ID: 25352733)
1. Osmoprotectants suppress the production and activity of matrix metalloproteinases induced by hyperosmolarity in primary human corneal epithelial cells.
Deng R; Su Z; Hua X; Zhang Z; Li DQ; Pflugfelder SC
Mol Vis; 2014; 20():1243-52. PubMed ID: 25352733
[TBL] [Abstract][Full Text] [Related]
2. Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress.
Hua X; Su Z; Deng R; Lin J; Li DQ; Pflugfelder SC
Curr Eye Res; 2015 Jul; 40(7):657-67. PubMed ID: 25271595
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells.
Li DQ; Chen Z; Song XJ; Luo L; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4302-11. PubMed ID: 15557436
[TBL] [Abstract][Full Text] [Related]
4. Effects of osmoprotectants on hyperosmolar stress in cultured human corneal epithelial cells.
Corrales RM; Luo L; Chang EY; Pflugfelder SC
Cornea; 2008 Jun; 27(5):574-9. PubMed ID: 18520508
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase expression and activity following prostaglandin F(2 alpha)-induced luteolysis.
Ricke WA; Smith GW; Smith MF
Biol Reprod; 2002 Mar; 66(3):685-91. PubMed ID: 11870075
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of osmoprotectants on prevention and treatment of murine dry eye.
Chen W; Zhang X; Li J; Wang Y; Chen Q; Hou C; Garrett Q
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6287-97. PubMed ID: 23970467
[TBL] [Abstract][Full Text] [Related]
7. Protective Effects of L-Carnitine Against Oxidative Injury by Hyperosmolarity in Human Corneal Epithelial Cells.
Hua X; Deng R; Li J; Chi W; Su Z; Lin J; Pflugfelder SC; Li DQ
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5503-11. PubMed ID: 26284556
[TBL] [Abstract][Full Text] [Related]
8. Combined hyperosmolarity and inflammatory conditions in stressed human corneal epithelial cells and macrophages to evaluate osmoprotective agents as potential DED treatments.
López-Cano JJ; González-Cela-Casamayor MA; Andrés-Guerrero V; Herrero-Vanrell R; Benítez-Del-Castillo JM; Molina-Martínez IT
Exp Eye Res; 2021 Oct; 211():108723. PubMed ID: 34384756
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
10. Hyperosmolarity disrupts tight junction
Zhang Y; Yang M; Zhao SX; Nie L; Shen LJ; Han W
Int J Ophthalmol; 2022; 15(5):683-689. PubMed ID: 35601157
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress markers induced by hyperosmolarity in primary human corneal epithelial cells.
Deng R; Hua X; Li J; Chi W; Zhang Z; Lu F; Zhang L; Pflugfelder SC; Li DQ
PLoS One; 2015; 10(5):e0126561. PubMed ID: 26024535
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta1 stimulates production of gelatinase (MMP-9), collagenases (MMP-1, -13) and stromelysins (MMP-3, -10, -11) by human corneal epithelial cells.
Kim HS; Shang T; Chen Z; Pflugfelder SC; Li DQ
Exp Eye Res; 2004 Aug; 79(2):263-74. PubMed ID: 15325573
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium.
Tao Y; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):345-54. PubMed ID: 7843905
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage.
Keeling J; Herrera GA
Kidney Int; 2005 Oct; 68(4):1590-603. PubMed ID: 16164636
[TBL] [Abstract][Full Text] [Related]
15. Effect of fluoroquinolones on the expression of matrix metalloproteinase in debrided cornea of rats.
Sharma C; Velpandian T; Baskar Singh S; Ranjan Biswas N; Bihari Vajpayee R; Ghose S
Toxicol Mech Methods; 2011 Jan; 21(1):6-12. PubMed ID: 21058936
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
Eagleton MJ; Peterson DA; Sullivan VV; Roelofs KJ; Ford JA; Stanley JC; Upchurch GR
J Surg Res; 2002 May; 104(1):15-21. PubMed ID: 11971672
[TBL] [Abstract][Full Text] [Related]
17. Regulation of MMP-9 production by human corneal epithelial cells.
Li DQ; Lokeshwar BL; Solomon A; Monroy D; Ji Z; Pflugfelder SC
Exp Eye Res; 2001 Oct; 73(4):449-59. PubMed ID: 11825017
[TBL] [Abstract][Full Text] [Related]
18. Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.
Ikema K; Matsumoto K; Inomata Y; Komohara Y; Miyajima S; Takeya M; Tanihara H
Exp Eye Res; 2006 Dec; 83(6):1396-404. PubMed ID: 16968651
[TBL] [Abstract][Full Text] [Related]
19. Role of matrix metalloproteinase-9 in ex vivo expansion of human limbal epithelial cells cultured on human amniotic membrane.
Sun CC; Cheng CY; Chien CS; Pang JH; Ku WC; Chen PY; Yang CM
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):808-15. PubMed ID: 15728535
[TBL] [Abstract][Full Text] [Related]
20. IL-36α/IL-36RA/IL-38 signaling mediates inflammation and barrier disruption in human corneal epithelial cells under hyperosmotic stress.
Li JM; Lu R; Zhang Y; Lin J; Hua X; Pflugfelder SC; Li DQ
Ocul Surf; 2021 Oct; 22():163-171. PubMed ID: 34428579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
